中文
|
English
Home
|
Help
|
Contact
Return
Adjuvant Trastuzumab Is Required in Human Epidermal Growth Factor Receptor 2-Positive Node-Negative Breast Cancer Patients Regardless of Tumour Size
10.4048/jbc.2020.23.e62
Author:
Laura BENDER
1
; Jean-Emmanuel KURTZ ; Thierry PETIT ; Xavier PIVOT
Author Information
1. Department of Oncology, Institut de Cancérologie Strasbourg, Strasbourg, France
Publication Type:
Letter to the Editor
From:
Journal of Breast Cancer 2020;23(6):672-673
Country
Republic of Korea
Language:
English